Aptapharma Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APTAPHARMA INC, and what generic and branded alternatives to APTAPHARMA INC drugs are available?
APTAPHARMA INC has five approved drugs.
Drugs and US Patents for Aptapharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aptapharma Inc | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | SOLUTION;ORAL | 216953-001 | Nov 15, 2022 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aptapharma Inc | SILDENAFIL CITRATE | sildenafil citrate | FOR SUSPENSION;ORAL | 213041-001 | Aug 6, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aptapharma Inc | CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 212053-001 | Sep 14, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.